The first installment of our new predictive index shows that dealmakers expect overall M&A to increase, with health care outperforming the overall market READ MORE 


ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld


GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market


Financial Services Companies Heat Up M&A Market
Speakers from Flexpoint Ford, Genstar Capital, Baird Capital, Madison Capital Funding and Katten Muchin Rosenman discuss the various factors playing a role in M&A activity within the financial services space

Expert's Corner

Pursuing Pharma Manufacturing
The fragmented pharmaceutical manufacturing industry provides plenty of opportunities for private equity investors, says JLL Partners founder Paul Levy

Today's Transactions:
Perrigo Buys Rest of Cobrek for $45M

The Nicotine Gum maker ups its stake in Cobrek, a drug development company

Perrigo Co. (Nasdaq: PRGO) has completed its acquisition of Cobrek Pharmaceuticals Inc., a Chicago drug-development company, for $45 million in cash.

The buyer already held an 18.5 percent stake in Cobrek, which it purchased in May 2008.

Rolling Meadows, Ill.- based Cobrek has two U.S. Food and Drug Administration-approved products that will be launched in 2013.  The company’s new products are generic versions of Luxiq Foam and Olux-E Foam, which help with skin itchiness.

Perrigo, headquartered in Allegan, Mich., develops products, such as Aller-Ease, Nicotine Gum and Clear Lax.


For more information on related topics, visit the following: